Every Form 4 that OraSure Technologies Inc (OSUR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OSUR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OSUR filings page.
ORASURE TECHNOLOGIES INC (OSUR) director John P. Kenny reported a Form 4 transaction involving 5,116 shares of common stock on September 6, 2026. The shares were withheld at a price of $3.4275 per share to pay tax liability associated with vesting of restricted shares, and he held 204,598 shares directly afterward.
OraSure Technologies director Steven Kyle Boyd received a stock-based fee grant. He was awarded 3,666 shares of common stock at a reference price of $4.4325 per share as a grant or award acquisition.
The footnote explains these are restricted shares granted under the OraSure Technologies, Inc. Stock Award Plan, with immediate vesting on the grant date. The shares were issued in lieu of cash director fees, at Boyd's election under the company's Director Compensation Policy. After this grant, he directly owns 163,234 common shares.
McMahon Robert W. reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director Robert W. McMahon received an equity grant as board compensation. He was awarded 46,106 shares of common stock as restricted stock, at no cash cost, increasing his direct holdings to 123,137 shares.
The restricted shares were granted under the OraSure Technologies, Inc. Stock Award Plan and will vest in full on the earlier of June 3, 2027 or immediately before the company’s 2027 Annual Meeting of Stockholders. Vesting will stop, and unvested shares will not vest, if he voluntarily leaves the Board of Directors before that time.
Gagliano Nancy J reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director Nancy J. Gagliano received a grant of 46,106 shares of common stock as a stock award. The grant consists of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, provided as compensation rather than an open-market purchase.
The restricted shares will vest in full on the earlier of June 3, 2027, or immediately before the start of the company’s 2027 annual stockholders meeting, as long as she continues serving on the board. Vesting will stop immediately if she voluntarily leaves the board, so the award is tied to ongoing service. Following this grant, she holds 185,055 shares directly.
Marmora Lelio reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director Lelio Marmora received a grant of 46,106 shares of Common Stock as a stock award, not through an open-market purchase. The shares were granted at no cash cost as part of the OraSure Technologies, Inc. Stock Award Plan.
The restricted shares will vest in full on the earlier of June 3, 2027, or immediately before the start of the company’s 2027 Annual Meeting of Stockholders, provided Marmora continues to serve on the board. Vesting stops immediately if he voluntarily leaves the board. After this grant, he directly holds 148,460 shares.
Kenny John P. reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director John P. Kenny received a grant of 46,106 shares of Common Stock as a stock award. The grant was made at a price of $0.00 per share, increasing his direct holdings to 209,714 shares after the transaction.
According to the award terms, these restricted shares will vest in full on the earlier of June 3, 2027 or immediately before the start of the company’s 2027 Annual Meeting of Stockholders. Vesting will stop immediately if he voluntarily leaves the Board before that time.
Bertrand John D. reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director John D. Bertrand received a grant of 46,106 shares of Common Stock as an equity award. The shares are restricted and were granted at no cash cost to him.
The award vests in full on the earlier of June 3, 2027 or immediately before the company’s 2027 Annual Meeting of Stockholders, provided he continues serving on the Board. Vesting stops if he voluntarily leaves the Board, meaning unvested shares would not be earned. After this grant, he directly holds 79,767 OraSure shares.
Boyd Steven Kyle reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director Steven Kyle Boyd received a grant of 46,106 shares of common stock as a restricted stock award. The shares were granted at no cash cost to him and are part of the OraSure Technologies, Inc. Stock Award Plan.
These restricted shares will vest in full on the earlier of June 3, 2027, or immediately before the start of the company’s 2027 Annual Meeting of Stockholders, as long as he continues to serve on the Board. If he voluntarily leaves the Board before that time, vesting stops immediately. After this grant, Boyd directly holds 159,568 OraSure shares.
OraSure Technologies Inc. director Steven Kyle Boyd reported a series of open-market purchases of the company’s Common Stock. Over three days, he bought a total of 75,000 shares at prices between $2.98 and $3.02 per share. Following these transactions, he directly owned 113,462 shares.
Bertrand John D. reported acquisition or exercise transactions in this Form 4 filing.
OraSure Technologies director John D. Bertrand received a grant of 33,661 shares of common stock as an equity award. The shares were granted at no cash cost to him and are structured as restricted stock. They cliff vest on May 12, 2028, meaning the entire award vests at once on that date if he continues serving on the Board. Vesting stops immediately if he voluntarily leaves the Board before that date.
OraSure Technologies director Lelio Marmora reported a routine share disposition related to taxes, not an open-market trade. On the vesting of restricted shares, 28,406 common shares were withheld at $3.02 per share to cover associated tax liabilities.
After this tax-withholding disposition, Marmora directly holds 102,354 shares of OraSure Technologies common stock. This type of transaction is compensation-related and does not represent a discretionary purchase or sale in the open market.
OraSure Technologies director Robert W. McMahon reported a tax-withholding disposition of 22,888 shares of Common Stock at $3.02 per share. These shares were withheld to cover taxes due on the vesting of restricted shares, and McMahon now directly holds 77,031 shares.
OraSure Technologies director Nancy J. Gagliano reported a tax-related share disposition. On the vesting of restricted shares, 21,305 shares of common stock were withheld at a price of $3.02 per share to cover associated tax liabilities. After this withholding, she directly holds 138,949 OraSure common shares.
OraSure Technologies director Steven Kyle Boyd reported routine equity compensation activity. He received a grant of 5,246 shares of common stock at $3.0975 per share value under the company’s Stock Award Plan, with immediate vesting and issued in lieu of cash director fees.
To cover taxes on the vesting, 1,416 shares were withheld, a non-market disposition used to pay the related tax liability. After these transactions, Boyd directly owns 38,462 shares of OraSure common stock. The filing reflects standard board compensation rather than open-market buying or selling.
OraSure Technologies Chief Financial Officer Kenneth J. McGrath reported an open-market purchase of 32,300 shares of common stock. The trade occurred on March 20, 2026 at a weighted average price of $2.9288 per share, with individual prices ranging from $2.86 to $2.98.
After this transaction, McGrath directly holds 589,562 OraSure shares. The purchase was carried out under a pre-arranged Rule 10b5-1 trading plan that he adopted on November 28, 2025, indicating the buying activity was scheduled in advance rather than timed discretionarily.
OraSure Technologies President & CEO Carrie Eglinton-Manner bought 32,300 shares of common stock in an open-market transaction. The shares were purchased on March 20, 2026 at a weighted average price of $2.9287 per share under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2025.
After this purchase, she directly owns 2,190,874 OraSure shares. The filing notes the shares were acquired through multiple trades within a price range of $2.86 to $2.98 per share.
OraSure Technologies senior vice president of finance and chief accounting officer Anthony Michele Marie reported routine equity compensation activity in common stock. On March 2, 2026, she received a grant of 42,982 shares of restricted stock that vest in three equal annual installments beginning on March 2, 2027, contingent on continued service.
On March 1, 2026, she acquired 14,183 shares in settlement of vested performance units, then had 4,062 shares and 10,817 shares withheld at $3.0425 per share to cover tax liabilities tied to vesting of performance units and restricted shares. After these transactions, she directly held 185,788 shares of OraSure common stock.
OraSure Technologies’ Chief Financial Officer Kenneth J. McGrath reported an open-market purchase of 22,021 shares of common stock. The shares were bought on March 13, 2026 at a weighted average price of $2.9985 per share, in multiple trades between $2.93 and $3.12. Following this transaction, he directly owns 557,262 shares. The purchase was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 28, 2025.
OraSure Technologies President & CEO Carrie Eglinton Manner purchased 22,022 shares of common stock in an open-market transaction at a weighted average price of $2.9985 per share.
The trade was executed under a pre-arranged Rule 10b5-1 trading plan, and following this purchase she directly owns 2,158,574 OraSure shares.
OraSure Technologies’ Chief Financial Officer Kenneth J. McGrath reported equity award activity in company stock. On March 1 and March 2, he acquired 88,348 and 26,814 shares of common stock at $0.00 per share through grants and settlement of vested performance units and restricted stock. On March 1, 7,639 and 20,745 shares were withheld at $3.0425 per share to cover tax liabilities tied to these vestings, rather than open-market sales. After these transactions, he directly owned 535,241 shares. The newly granted restricted stock is scheduled to vest in three equal annual installments beginning on March 2, 2027, conditioned on his continued service.
OraSure Technologies President & CEO Carrie Eglinton Manner reported equity compensation and related tax withholding transactions in company common stock. On March 2, 2026, she received a grant of 355,464 shares of restricted stock that vest in three equal annual installments beginning March 2, 2027, conditioned on continued service.
On March 1, 2026, she acquired 129,032 shares delivered in settlement of vested performance units and had 56,116 and 122,655 shares withheld at $3.0425 per share to cover tax liabilities tied to vesting of performance units and restricted shares. After these transactions, she directly owned 2,136,552 common shares.
OraSure Technologies (OSUR) director John P. Kenny received 6,118 restricted shares on 09/24/2025 under the company's Stock Award Plan in lieu of cash fees. The shares were granted at an indicated price of $3.269 and vest immediately, increasing Mr. Kenny's beneficial ownership to 153,322 shares. The Form 4 was signed by an attorney-in-fact on 09/26/2025. The filing records this as a non-derivative acquisition and specifies the grant was made under the company plan as compensation for director fees.